Canada markets closed

CSPC Pharmaceutical Group Limited (CVG.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.9794-0.0034 (-0.35%)
At close: 08:06AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 12.03B
Enterprise Value 10.22B
Trailing P/E 14.85
Forward P/E 11.63
PEG Ratio (5 yr expected) 1.64
Price/Sales (ttm)2.76
Price/Book (mrq)2.92
Enterprise Value/Revenue 0.34
Enterprise Value/EBITDA 1.48

Trading Information

Stock Price History

Beta (5Y Monthly) 0.70
52-Week Change 3-3.65%
S&P500 52-Week Change 3-15.36%
52 Week High 31.1465
52 Week Low 30.8368
50-Day Moving Average 30.9807
200-Day Moving Average 30.9758

Share Statistics

Avg Vol (3 month) 31.33k
Avg Vol (10 day) 3217
Shares Outstanding 511.93B
Implied Shares Outstanding 6N/A
Float 88.36B
% Held by Insiders 129.56%
% Held by Institutions 133.22%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 42.60%
Trailing Annual Dividend Rate 30.17
Trailing Annual Dividend Yield 316.89%
5 Year Average Dividend Yield 41.40
Payout Ratio 432.80%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 08, 2022
Last Split Factor 28:5
Last Split Date 3Oct 16, 2020

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2021
Most Recent Quarter (mrq)Jun 30, 2022

Profitability

Profit Margin 18.58%
Operating Margin (ttm)22.37%

Management Effectiveness

Return on Assets (ttm)11.57%
Return on Equity (ttm)20.49%

Income Statement

Revenue (ttm)29.65B
Revenue Per Share (ttm)2.48
Quarterly Revenue Growth (yoy)9.10%
Gross Profit (ttm)21.14B
EBITDA 7.41B
Net Income Avi to Common (ttm)5.51B
Diluted EPS (ttm)0.0700
Quarterly Earnings Growth (yoy)-1.80%

Balance Sheet

Total Cash (mrq)13.97B
Total Cash Per Share (mrq)1.17
Total Debt (mrq)682.56M
Total Debt/Equity (mrq)2.32
Current Ratio (mrq)2.70
Book Value Per Share (mrq)2.35

Cash Flow Statement

Operating Cash Flow (ttm)6.15B
Levered Free Cash Flow (ttm)3.01B